K Pharma,Inc.

¥615.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4896Healthcare
Country Japan
PE (Fwd) •••
TSR 3Y CAGR (4.95%)
Div yield —
ROE (80.51%)
Biotechnology
Beta (5Y) 0.48
PE TTM —
TSR TTM (1.76%)
Mkt cap ¥7.148B
ROIC (28.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥603
(2.01%)
(81.75%)
Hold 10|12|9|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
6.55
6.33
6.20
6.29
19.34%
19.95%
12.98%
3.54%
Revenue¥M
669.1
685.0
700.8
681.1
(3.79%)
0.64%
2.70%
0.26%
Peers (US$45.38M)
Cap (US$)
PE
44.18M
—
43.88M
—
45.23M
26.89x
Capital
TTM
5Y
10Y
Leveragex
0.560
0.706
0.496
EBIT/Intx
0.251
2.687
2.742
Own earn%
(81.88)
77.70
76.47
Sh yield%
46.66
44.20
42.26
Owners
Insiders/Inst%
9.95
80.93
Short interest%
1.17
SBC / revenue%
1.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
1–4
$1 testx
0.0
Incr. ROIC%
2